QIAGEN N.V. QGEN has expanded its Master Collaboration Agreement with AstraZeneca AZN to develop and commercialize companion diagnostics (CDx) for AstraZeneca’s future therapies targeting chronic diseases. The collaboration w
https://www.nasdaq.com/articles/qiagen-and-astrazeneca-expand-pact-develop-cdx-chronic-diseases